On the future of genetic risk assessment

Next-generation sequencing (NGS) techniques have greatly accelerated the molecular elucidation of Mendelian disorders, and affordable NGS-based diagnostic tests are around the corner that promise to detect or rule out mutations in specific subsets of the known disease genes. Whole exome sequencing and shortly afterwards whole genome sequencing (WGS) will become an even more comprehensive alternative to such targeted tests. In view of the current enthusiasm to implement these methods, but also given their rapidly dropping costs, it is quite possible that WGS will soon be adopted as universal intake test in Clinical Genetics. Central databases and large-scale genotype–phenotype comparisons will be required to progressively identify the clinically relevant sequence variants and to distinguish them from neutral polymorphisms in the human genome, and these databases will become indispensable for the interpretation of individual genome sequences. In this scenario, there will be massively growing demand for genetic counselling, but the need for experienced syndromologists will not increase proportionally, as the success of the diagnostic process will become far less dependent on the ability of clinical geneticists to reliably recognize genetic syndromes.

[1]  Z. Xuan,et al.  Genome-wide in situ exon capture for selective resequencing , 2007, Nature Genetics.

[2]  Timothy B. Stockwell,et al.  The Diploid Genome Sequence of an Individual Human , 2007, PLoS biology.

[3]  J. Dungan,et al.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011 .

[4]  D. Cutler,et al.  Targeted sequencing of the human X chromosome exome. , 2011, Genomics.

[5]  J. Maguire,et al.  Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing , 2009, Nature Biotechnology.

[6]  David R. Murdock,et al.  Whole-Genome Sequencing for Optimized Patient Management , 2011, Science Translational Medicine.

[7]  Christian Gilissen,et al.  Unlocking Mendelian disease using exome sequencing , 2011, Genome Biology.

[8]  Emily H Turner,et al.  Target-enrichment strategies for next-generation sequencing , 2010, Nature Methods.

[9]  Ryan W. Kim,et al.  Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing , 2011, Science Translational Medicine.

[10]  H. Ropers.  New perspectives for the elucidation of genetic disorders. , 2007, American journal of human genetics.

[11]  A. Addington,et al.  Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. , 2009, The New England journal of medicine.

[12]  Wei Chen,et al.  Deep sequencing reveals 50 novel genes for recessive cognitive disorders , 2011, Nature.

[13]  Jacob D. Jaffe,et al.  Mutations in MTFMT underlie a human disorder of formylation causing impaired mitochondrial translation. , 2011, Cell metabolism.

[14]  H. Ropers.  Genetics of early onset cognitive impairment. , 2010, Annual review of genomics and human genetics.

[15]  S. Kingsmore,et al.  Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Become Routine? , 2011, Science Translational Medicine.

[16]  Alex Karagrigoriou,et al.  Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21 , 2011, Nature Medicine.

[17]  P. Stenson,et al.  Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics , 2010, Human mutation.

[18]  S. Turner,et al.  Real-Time DNA Sequencing from Single Polymerase Molecules , 2009, Science.

[19]  J. Shendure.  Next-generation human genetics , 2011, Genome Biology.

[20]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[21]  Nancy F. Hansen,et al.  Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.

[22]  H. Ropers.  Single gene disorders come into focus - again , 2010, Dialogues in clinical neuroscience.

[23]  Huanming Yang,et al.  Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants , 2010, Nature Genetics.

[24]  Hao Hu,et al.  Mutation screening in 86 known X-linked mental retardation genes by droplet-based multiplex PCR and massive parallel sequencing , 2009, The HUGO Journal.

[25]  Elizabeth T. Cirulli,et al.  The Characterization of Twenty Sequenced Human Genomes , 2010, PLoS genetics.

[26]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[27]  J. Lupski,et al.  The complete genome of an individual by massively parallel DNA sequencing , 2008, Nature.

[28]  Raymond K. Auerbach,et al.  The real cost of sequencing: higher than you think! , 2011, Genome Biology.

[29]  E. Mardis.  Next-generation DNA sequencing methods. , 2008, Annual review of genomics and human genetics.